KEAP1 and non-small cell lung carcinoma: In several studies, KEAP1 mutation has been found to be related to chemotherapy resistance, while understanding of the influence of KEAP1 mutation on immunotherapy in NSCLC patients is still controversial (Zhu et al., 2021).